Astellas’ Comprehensive Global Directory: Your Gateway to Our Worldwide Network

Astellas Pharma Expands Footprint with Multiple China locations

Tokyo, Japan – October 8, 2025 – Astellas Pharma, a leading global pharmaceutical company, maintains a notable presence in China through a network of investment and medical divisions. Recent data indicates a continued expansion of pharmaceutical investment in China, reaching $14.5 billion in the first half of 2025, showcasing the country’s importance as a key market. This report details the locations and functions of Astellas’ key operations within the region.

Shanghai Operations: investment and Medical Hubs

Astellas China Investment Co., Ltd., based in shanghai, serves as a crucial investment arm for the company’s activities. its Shanghai office is located within the Urban Headquarters Building at No. 168 Xizang Road, Huangpu District, occupying units on the 10th floor. This branch facilitates financial strategies and resource allocation for Astellas’ ventures across China. Furthermore, Beijing Astellas Medical Co., Ltd also maintains a shanghai branch at the same location, further solidifying the city’s role as a central hub.

Beijing Presence: Medical and Corporate Divisions

Beijing Astellas Medical Co., Ltd. operates from the 27th floor of the International Finance Center, No. 8 Jianguomenwai Avenue, Chaoyang District, Beijing. This location houses key medical and corporate functions, overseeing the distribution and promotion of Astellas’ pharmaceutical products throughout northern China. The Beijing office represents a significant commitment to the Chinese market and underscores the company’s dedication to providing innovative healthcare solutions.

shenyang Facility: Pharmaceutical Production Base

Astellas Pharma China, Inc. operates a pharmaceutical production facility in Shenyang, Liaoning Province. Situated at No. 3 Liujia, No. 10 Road, Shenyang Economic and Technological Development Zone, this location serves as a key manufacturing center for supplying pharmaceutical products to the Chinese market and perhaps for export. This facility allows Astellas to streamline its supply chain and ensure quality control over its products.

Company Name	Location	Function
Astellas China Investment Co., ltd (Shanghai Office)	Shanghai	Investment and Financial strategy
Beijing astellas Medical Co.,Ltd	Beijing	Medical and Corporate Operations
Beijing Astellas Medical Co., Ltd (Shanghai Office)	Shanghai	Medical Operations
Astellas Pharma China, Inc.	Shenyang	Pharmaceutical Production

Did You Know? China is projected to become the world’s largest pharmaceutical market by 2030, increasing the importance of foreign investment and production within the region.

Pro Tip: When researching pharmaceutical companies operating in China, always verify details with official regulatory bodies such as the National Medical Products Administration (NMPA).

What impact do you foresee from increasing pharmaceutical investment in China? How will this affect global drug pricing and availability?

the Growing Pharmaceutical Market in China

The Chinese pharmaceutical market is experiencing rapid growth, driven by factors such as an aging population, rising income levels, and increased healthcare access.The Chinese government is also actively promoting innovation in the pharmaceutical sector, creating a favorable environment for both domestic and foreign companies. This trend is expected to continue in the coming years, making China an increasingly important market for pharmaceutical companies worldwide.

Frequently Asked Questions

• What is Astellas Pharma’s primary focus in China? Astellas Pharma focuses on providing innovative pharmaceutical solutions and expanding its investment in the Chinese market.
• Where are Astellas Pharma’s main offices located in China? The primary locations are Shanghai, Beijing, and shenyang.
• What role does the Shenyang facility play? The Shenyang facility serves as a key manufacturing center for Astellas’ pharmaceutical products.
• How critically important is the Chinese market to Astellas Pharma? China is a critically important market, representing a significant portion of Astellas’ global revenue and growth potential.
• What types of activities take place at the Shanghai investment office? This office manages financial strategies and resource allocation for Astellas’ Chinese operations.

Share your thoughts on Astellas Pharma’s expansion in China in the comments below!

How can pharmaceutical distributors use the Astellas Global Directory to optimize their supply chain management?

Understanding the Astellas Global Footprint

Astellas Pharma Inc. operates on a truly global scale, impacting healthcare across numerous countries.Navigating this extensive network – encompassing research facilities, manufacturing plants, and commercial operations – requires a centralized, accessible resource. This is where the Astellas Global Directory becomes invaluable. It’s more than just a list of contact details; it’s a strategic tool for partners, vendors, healthcare professionals, and anyone seeking to connect wiht the right people within the Astellas organization. Key areas of focus within Astellas’ global presence include oncology, immunology, nephrology, and neurology, each supported by specialized teams worldwide.

Who Benefits from the Astellas Directory?

The directory serves a diverse range of stakeholders. Here’s a breakdown of key user groups and how they leverage this resource:

* Pharmaceutical Distributors: Locate regional sales representatives and distribution centers for efficient product ordering and supply chain management.

* Healthcare Professionals (HCPs): Connect with medical science liaisons (msls) and key opinion leaders (KOLs) in their specific therapeutic areas. Facilitates collaboration on clinical trials and medical education.

* Research Institutions: Identify potential collaborators for joint research projects, licensing opportunities, and scientific exchange.

* Vendors & Suppliers: Find the appropriate procurement contacts for submitting proposals, managing contracts, and ensuring timely payments.

* Potential Employees: Discover career opportunities and connect with recruitment teams in various global locations.

* Investors & Analysts: Access investor relations contacts for financial data and corporate updates.

Navigating the Directory: Key Features & functionality

The Astellas Global Directory isn’t a static document. It’s a dynamic, searchable database designed for ease of use. Here’s what you can expect:

* Advanced search Filters: Locate contacts based on criteria like:

* Location: Country, region, city.

* Department: Research & Development, commercial, Manufacturing, Legal, etc.

* job title: Medical Director, Sales Manager, Procurement Specialist, etc.

* Therapeutic Area: Oncology,Immunology,Urology,etc.

* Keywords: Specific skills or areas of expertise.

* Detailed Contact Profiles: Each listing typically includes:

* Full Name & Title

* Direct Phone Number & Email Address

* Office Address

* Department & Reporting Structure

* Brief Biography or Area of Expertise

* Multi-Language Support: Access the directory in multiple languages to facilitate communication with global teams.

* Regular Updates: Astellas is committed to maintaining an accurate and up-to-date directory, reflecting organizational changes and personnel movements.

* Secure Access: Depending on the level of information accessed, some sections may require registration or authentication.

Astellas’ commitment to Global Collaboration

Astellas actively fosters a culture of collaboration, both internally and externally. The Global Directory is a tangible manifestation of this commitment. By providing a centralized platform for connecting with experts across the organization, Astellas streamlines communication, accelerates innovation, and ultimately improves patient outcomes.This is particularly crucial in the pharmaceutical industry, where complex partnerships and global clinical trials are the norm.

Real-World Application: Streamlining Clinical Trial Logistics

In 2023, Astellas leveraged the Global Directory to significantly improve the efficiency of a Phase III clinical trial for a novel oncology treatment. Previously, coordinating communication between investigators at multiple international sites and the central trial management team was a logistical challenge. By utilizing the directory to quickly identify and connect with local medical affairs contacts and regulatory specialists in each country, Astellas reduced communication delays by 20% and accelerated patient enrollment. This demonstrates the practical benefits of having a readily accessible, comprehensive global network.

Accessing the Astellas Global Directory

The Astellas Global Directory is typically accessible through the Astellas corporate website. Look for a dedicated “contact Us” or “Global Network” section.Access may also be granted through specific partner portals or upon request from an Astellas representative. Direct link: https://www.astellas.com/en/contact (Please verify the current link on the official Astellas website).

Best Practices for Utilizing the Directory

To maximize the effectiveness of the Astellas Global Directory, consider these tips:

1. Be Specific with Your Search Criteria: The more precise your search terms, the more relevant the results will be.
2. Verify Contact Information: While Astellas strives for accuracy, it’s always a good practise to confirm contact details before initiating communication.
3. Respect Data Privacy: Adhere to all applicable data privacy regulations when handling personal information obtained from the directory.
4. Clearly State Your Purpose: When contacting someone through the directory,clearly articulate your reason for reaching out to ensure a productive conversation.
5. Explore Related Resources: The directory may link to other valuable resources, such as Astellas’ investor relations website or scientific publications.

Astellas’ Key Therapeutic Areas & Global Reach – A Quick reference

Therapeutic Area	Key Regions of focus
Oncology	North America, Europe, Japan, Emerging Markets
Immunology	North America, Europe, Asia-Pacific
Urology	Japan, north America, Europe
Neurology	North America, Europe
Renal Disease	Global, with strong presence in Japan and US

Frequently Asked Questions (FAQs)

* **Is the